LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024.

Revenue
+11.3%
EPS
−14.3%
Free cash flow
−25.8%
Total debt
+0.53%

Quarter to September 2026, against a year earlier

80.70 2.79 −3.34%
Market cap
$1.9B
P/E
29.7×
Fwd P/E
28.2×
Dividend yield
1.15%
F-score
6/9
Altman Z
6.99
Beneish M
−2.61
Dividend safety
93/100

LeMaitre Vascular, Inc. (LMAT) Free cash flow

Alert me on Free cash flow

LeMaitre Vascular, Inc.'s free cash flow for fiscal 2025 was $74.5M, up 100.4% from $37.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $67.0M. Over the past ten years it has ranged from $9.2M (fiscal 2015) to $74.5M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. LeMaitre Vascular, Inc. ranks 19th of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $74.5M 100.39%
FY2024 $37.2M 26.03%
FY2023 $29.5M 28.16%
FY2022 $23.0M (23.87%)
FY2021 $30.2M (10.70%)
FY2020 $33.8M 224.83%
FY2019 $10.4M (36.68%)
FY2018 $16.5M 0.01%
FY2017 $16.5M 17.06%
FY2016 $14.1M 53.37%

Quarterly newest first

Period Free cash flow Change
Sep 2026 $19.7M 43.99%
Jun 2026 $13.7M 10.90%
Mar 2026 $12.3M (42.42%)
Dec 2025 $21.4M (19.27%)
43 more quarters

Against its own ten years

Low $9.2M High $74.5M
Ten-year median $23.0M
Current reading's percentile 100

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on LMAT